Earnings calendar/MMED
MiniMed Group, Inc. (MMED)
MiniMed Group, Inc. (MMED) Q1 FY2027 (quarter ended ), 10-Q filed (accession 0001628280-26-060926): revenue $843.0M, net income $0, diluted EPS $0.00. Trailing four filed quarters ( to ): revenue $3.3B, diluted EPS -$1.78. Figures from the SEC filing, in USD, as reported.
Quarter-by-quarter results read from the company's own filed statements — period end, filing date, diluted EPS, revenue and year-over-year change. Consensus estimates are shown only where one exists.
Latest filed quarter
The most recent quarter MiniMed Group, Inc. has filed, from EvidInvest's standardized statements.
Period end
Jul 31, 2026
Q1 FY2027
EPS (diluted)
$0.00
Est. $0.12 · -100.0%
Revenue
$843.0M
Est. $826.8M · +2.0%
Net income
$0
As filed
EPS YoY
+100.0%
vs quarter ended 2025-07-25
Revenue YoY
+16.6%
vs quarter ended 2025-07-25
Next report
Dec 30, 2026
Third-party calendar date, not confirmed by a company filing · est. EPS $0.12
Run-rate
Trailing twelve months, summed from the last four filed quarters.
TTM EPS (diluted)
$-1.78
2026-01-31 through 2026-07-31
TTM revenue
$3.31B
2026-01-31 through 2026-07-31
Filed quarters
11
On record here
Next revenue estimate
$825.2M
Consensus, where one exists
Filed quarters
One row per filed statement, newest first
| Period end | Filed | EPS diluted | Revenue | EPS YoY | Revenue YoY | Est. EPS | Surprise |
|---|---|---|---|---|---|---|---|
| 2026-07-31Q1 FY2027 | 2026-09-08 | $0.00 | $843.0M | +100.0% | +16.6% | $0.12 | -100.0% |
| 2026-04-30Q4 FY2025 | 2026-04-30 | $-0.68 | $837.0M | — | — | $-0.15 | -356.1% |
| 2026-04-24Q4 FY2026 | 2026-06-29 | $-0.68 | $837.0M | 0.0% | 0.0% | — | — |
| 2026-01-31Q3 FY2025 | 2026-01-31 | $-0.42 | $790.0M | — | +9.1% | $0.17 | -346.8% |
| 2026-01-23Q3 FY2026 | 2026-04-17 | $-0.47 | $790.0M | -11.9% | 0.0% | — | — |
| 2025-10-24Q2 FY2026 | 2026-04-17 | — | — | — | — | — | — |
| 2025-07-25Q1 FY2026 | 2026-09-08 | $-0.08 | $723.0M | — | — | — | — |
| 2025-04-25Q4 FY2025 | 2026-06-29 | — | $724.0M | — | — | — | — |
| 2025-01-24Q3 FY2025 | 2026-04-17 | $-0.04 | $687.0M | — | — | — | — |
| 2024-10-25Q2 FY2025 | 2026-04-17 | — | — | — | — | — | — |
| 2024-07-26Q1 FY2025 | 2026-04-17 | — | — | — | — | — | — |
Need MMED data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.